Amgen/Cytokinetics Phase III Heart Failure Data Are Below Expectations

Omecamtiv Met Primary, Missed Key Secondary Endpoints

 
• By Mandy Jackson
  
Paper heart
Omecamtiv reduced a composite of hospitalizations and deaths with no significant impact on deaths alone • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapeutic Category